Technical Analysis for AVXL - Anavex Life Sciences Corp.

Grade Last Price % Change Price Change
F 4.82 -5.68% -0.29
AVXL closed down 5.68 percent on Monday, March 18, 2024, on 1.17 times normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -5.68%
Volume Surge Other -5.68%
Bollinger Band Squeeze Range Contraction -5.68%

   Recent Intraday Alerts

Alert Time
Down 5% about 10 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Fell Below Lower Bollinger Band about 10 hours ago
2x Volume Pace about 15 hours ago
1.5x Volume Pace about 15 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Anavex Life Sciences Corp. Description

Anavex Life Sciences Corp., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of Alzheimer's disease, central nervous system diseases, and pain and various cancers. Its lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), which is in a Phase IIa clinical trial for the treatment of Alzheimer's disease. The company's product candidates also include ANAVEX 3-71, a drug candidate that is effective in very small doses against the major Alzheimer's hallmarks in transgenic (3xTg-AD) mice via sigma-1 receptor activation and M1 muscarinic allosteric modulation; ANAVEX 1-41, a sigma-1 agonist for neuroprotective application; and ANAVEX 1037, ANAVEX 1079, and ANAVEX 1519 for the treatment of pain and various cancers. Anavex Life Sciences Corp. was founded in 2006 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Pain Neuroscience Alzheimer's Disease Chemical Compounds Central Nervous System Disease Lewy Body Dementia Treatment Of Alzheimer's Disease Piperidines Neuroprotection

Is AVXL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.31
52 Week Low 4.795
Average Volume 1,310,814
200-Day Moving Average 7.10
50-Day Moving Average 5.70
20-Day Moving Average 5.15
10-Day Moving Average 5.15
Average True Range 0.32
RSI (14) 38.65
ADX 15.97
+DI 18.71
-DI 24.07
Chandelier Exit (Long, 3 ATRs) 5.01
Chandelier Exit (Short, 3 ATRs) 5.75
Upper Bollinger Bands 5.47
Lower Bollinger Band 4.83
Percent B (%b) -0.01
BandWidth 12.60
MACD Line -0.20
MACD Signal Line -0.23
MACD Histogram 0.0268
Fundamentals Value
Market Cap 395.78 Million
Num Shares 82.1 Million
EPS -0.54
Price-to-Earnings (P/E) Ratio -8.93
Price-to-Sales 0.00
Price-to-Book 3.50
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.33
Resistance 3 (R3) 5.38 5.27 5.25
Resistance 2 (R2) 5.27 5.14 5.24 5.22
Resistance 1 (R1) 5.04 5.06 4.99 4.99 5.19
Pivot Point 4.93 4.93 4.90 4.90 4.93
Support 1 (S1) 4.70 4.80 4.65 4.65 4.45
Support 2 (S2) 4.59 4.72 4.56 4.42
Support 3 (S3) 4.36 4.59 4.40
Support 4 (S4) 4.31